CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+16.26%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+25%)
Cap. Flow
+$7.99M
Cap. Flow
% of AUM
5.94%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$3.56M |
| 2 |
Alico
ALCO
|
$2.24M |
| 3 |
Exelixis
EXEL
|
$1.81M |
| 4 |
Elicio Therapeutics
ELTX
|
$1.69M |
| 5 |
National Healthcare
NHC
|
$1.56M |
Top Sells
| 1 |
Aterian
ATER
|
$7.23M |
| 2 |
Aviat Networks
AVNW
|
$3.95M |
| 3 |
VYNE Therapeutics
VYNE
|
$3.43M |
| 4 |
ClearPoint Neuro
CLPT
|
$3.34M |
| 5 |
Intel
INTC
|
$2.49M |
Sector Composition
| 1 | Healthcare | 40.52% |
| 2 | Financials | 13.92% |
| 3 | Technology | 12.04% |
| 4 | Energy | 10.02% |
| 5 | Materials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prudential Financial
PRU
$38.6B
| $1.09M | 0.81% | +12,000 | New | +$1.09M |
|
|
PRTK
52
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.06M | 0.79% | 150,000 +115,000 | +329% | +$812K |
|
53
Vital Energy
VTLE
$690M
| $1.05M | 0.78% | 35,000 | – | – |
|
54
IAMGOLD
IAG
$5.35B
| $1.04M | 0.78% | 350,000 +150,000 | +75% | +$447K |
|
55
Cytosorbents Corp
CTSO
$59.2M
| $1.04M | 0.77% | +120,000 | New | +$1.04M |
|
56
Theravance Biopharma
TBPH
$699M
| $1.02M | 0.76% | +50,000 | New | +$1.02M |
|
57
Nektar Therapeutics
NKTR
$568M
| $1M | 0.74% | 50,000 +15,000 | +43% | +$300K |
|
58
ACNB Corp
ACNB
$474M
| $996K | 0.74% | +34,000 | New | +$996K |
|
|
59
VYNE Therapeutics
VYNE
$8.16M
| $984K | 0.73% | 143,750 -500,448 | -78% | -$3.43M |
|
|
SPPI
60
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $978K | 0.73% | 300,000 +50,000 | +20% | +$163K |
|
|
BCEL
61
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $920K | 0.68% | 60,000 | – | – |
|
62
Smith Micro Software
SMSI
$15.5M
| $881K | 0.65% | 160,000 -40,000 | -20% | -$220K |
|
|
CSOD
63
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $872K | 0.65% | +20,000 | New | +$872K |
|
64
MGIC Investment
MTG
$6.42B
| $831K | 0.62% | +60,000 | New | +$831K |
|
65
Heron Therapeutics
HRTX
$207M
| $811K | 0.6% | 50,000 +35,000 | +233% | +$568K |
|
66
Eledon Pharmaceuticals
ELDN
$155M
| $803K | 0.6% | +75,000 | New | +$803K |
|
67
Travere Therapeutics
TVTX
$1.56B
| $799K | 0.59% | 32,000 | – | – |
|
|
CBAY
68
DELISTED
Cymabay Therapeutics
CBAY
| $681K | 0.51% | +150,000 | New | +$681K |
|
|
FLXN
69
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $671K | 0.5% | 75,000 | – | – |
|
70
Plains GP Holdings
PAGP
$3.82B
| $658K | 0.49% | 70,000 +45,000 | +180% | +$423K |
|
71
1st Source
SRCE
$1.58B
| $571K | 0.42% | 12,000 | – | – |
|
72
Preformed Line Products
PLPC
$941M
| $550K | 0.41% | 8,000 +2,830 | +55% | +$195K |
|
|
HGEN
73
DELISTED
HUMANIGEN, INC.
HGEN
| $478K | 0.36% | 25,000 -15,000 | -38% | -$287K |
|
74
EQT Corp
EQT
$32.4B
| $465K | 0.35% | +25,000 | New | +$465K |
|
75
Coterra Energy
CTRA
$18.7B
| $376K | 0.28% | +20,000 | New | +$376K |
|